Ending Discrimination in COVID–19 Treatments Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Mar 31, 2022)
Ending Discrimination in COVID-19 Treatments Act
This bill prohibits consideration of certain factors, including vaccination status, in decisions about an individual's access to federally provided monoclonal antibody therapies to treat COVID-19.
As a condition of receiving the therapies from the federal government, states must ensure that providers do not consider specified demographic characteristics, veteran status, or political ideology or speech when determining a patient's eligibility for such therapies.
What just happenedMar 31, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
- Introduced in SenateMar 31, 2022
- Mar 31, 2022IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee - Mar 31, 2022IntroReferral10000
Introduced in Senate